NCT02405754View on ClinicalTrials.gov

Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients.

CompletedOBSERVATIONAL
Enrollment

667

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

April 30, 2014

Study Completion Date

August 31, 2014

Conditions
Coronary Artery DiseaseAngina PectorisChest PainCardiovascular DiseasesCoronary Heart DiseaseCHDCVDCAD
Interventions
DIAGNOSTIC_TEST

Corus CAD (ASGES)

Age/Sex/Gene Expression Score - ASGES

Trial Locations (1)

45402

Providence Medical Group - Dayton Primary, Dayton

Sponsors

Lead Sponsor

CardioDx
All Listed Sponsors
lead

CardioDx

INDUSTRY

NCT02405754 - Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients. | Biotech Hunter | Biotech Hunter